Veralto Corp Ordinary Shares VLTO 深 沪
等待开盘 12-17 09:30:00 美东时间
99.34
-0.940
-0.94%
华盛通- 最 高101.075
- 今 开100.84
- 成交量 220.29万股
- 最 低 98.42
- 昨 收 100.28
- 总市值 246.36亿
- 52周最高 110.00
- 市盈率 静 29.77
- 换手率 0.89%
- 52周最低 83.645
- 委 比 -13.29%
- 总股本 2.48亿
- 历史最高 114.56
- 量 比 1.36
- 振 幅 2.65%
- 历史最低 64.71
- 每 手 1
- 风险率 4.52%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Veralto Raises Quarterly Cash Dividend From $0.11 To $0.13 Per Share
Veralto (NYSE:VLTO), a global leader in essential water and product quality solutions dedicated to Safeguarding the World's Most Vital Resources™, announced today that its board of directors has approved an 18%
12-16 21:12
Veralto Announces Increase in Quarterly Dividend
WALTHAM, Mass., Dec. 16, 2025 /PRNewswire/ -- Veralto (NYSE: VLTO), a global leader in essential water and product quality solutions dedicated to Safeguarding the World's Most Vital Resource...
12-16 21:00
美股大行评级 | 超配！大摩上调回声星通信评级；汽车地带、CBRL、金宝汤、家得宝等遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从8美元升至8.25美元；Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从12.5美元升至13美元
12-11 10:33
Jefferies Downgrades Veralto to Hold, Lowers Price Target to $105
Jefferies analyst Saree Boroditsky downgrades Veralto (NYSE:VLTO) from Buy to Hold and lowers the price target from $125 to $105.
12-10 21:18
美股大行评级 | 安捷伦科技、Keysight、先科电子获多家大行上调目标价；摩根大通下调亿航智能评级至"中性"，目标价下调至13美元
今日重点评级关注：HC Wainwright & Co.：维持BiomX"买入"评级，目标价从15美元升至26美元；Clear Street：维持Diversified Energy"买入"评级，目标价从23美元升至25美元
11-26 10:07
BMO Capital Maintains Outperform on Veralto, Lowers Price Target to $114
BMO Capital analyst John McNulty maintains Veralto (NYSE:VLTO) with a Outperform and lowers the price target from $123 to $114.
11-26 01:52
Veralto Agrees To Acquire In-Situ For $435M; Transaction Expected To Close In Q1 2026
Adds strategic, synergistic bolt-on with complementary water analytics technologies and channelsExpands presence in high-growth environmental water and hydrology marketsDemonstrates disciplined approach to capital
11-25 20:11
美股大行评级 | 绩后评级扎堆！高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；DoorDash、多邻国、Figma、飞塔信息、HubSpot等遭下调目标价
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
11-07 10:14
美股大行评级 | 最高350美元！16家大行上调谷歌目标价！Meta遭12家大行下调目标价；潜在涨幅1456.29%！NRX Pharmaceuticals获Ascendiant Capital升目标价至47美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从46美元升至47美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从27美元升至31美元
10-31 10:25
Barclays Maintains Overweight on Veralto, Raises Price Target to $121
Barclays analyst William Grippin maintains Veralto (NYSE:VLTO) with a Overweight and raises the price target from $119 to $121.
10-31 01:47
